Mechanisms of ferroptosis

Cellular and Molecular Life Sciences

Volumn 73, Issue 11-12, 2016, Pages 2195-2209

  Cao, Jennifer Yinuo ^a   Dixon, Scott J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Cancer; Cell death; Erastin; Ferrostatin 1; Glutathione; Glutathione peroxidase 4; Iron; Polyunsaturated fatty acid; RAS; Reactive oxygen species; Sorafenib

Indexed keywords

CYCLOHEXYLAMINE DERIVATIVE; FERROSTATIN-1; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IRON; LIPROXSTATIN-1; PHENYLENEDIAMINE DERIVATIVE; PHOSPHOLIPID-HYDROPEROXIDE GLUTATHIONE PEROXIDASE; QUINOXALINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SPIRO COMPOUND; UNSATURATED FATTY ACID;

BIOSYNTHESIS; CELL DEATH; CELL MEMBRANE; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

CELL DEATH; CELL MEMBRANE; CYCLOHEXYLAMINES; FATTY ACIDS, UNSATURATED; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IRON; NEOPLASMS; PHENYLENEDIAMINES; QUINOXALINES; REACTIVE OXYGEN SPECIES; SPIRO COMPOUNDS;

EID: 84962637563     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-016-2194-1     Document Type: Review

References (89)

1. Brennan MA, Cookson BT (2000) Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol Microbiol 38:31–40
2. Degterev A, Huang Z, Boyce M et al (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112–119. doi:10.1038/nchembio711
3. Fuchs Y, Steller H (2011) Programmed cell death in animal development and disease. Cell 147:742–758. doi:10.1016/j.cell.2011.10.033
4. +-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci USA 110:20364–20371. doi:10.1073/pnas.1319661110
5. Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060–1072. doi:10.1016/j.cell.2012.03.042
6. Yang WS, SriRamaratnam R, Welsch ME et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317–331. doi:10.1016/j.cell.2013.12.010
7. Skouta R, Dixon SJ, Wang J et al (2014) Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc 136:4551–4556. doi:10.1021/ja411006a
8. Linkermann A, Skouta R, Himmerkus N et al (2014) Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA 111:16836–16841. doi:10.1073/pnas.1415518111
9. Friedmann Angeli JP, Schneider M, Proneth B et al (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16:1180–1191. doi:10.1038/ncb3064
10. Gao M, Monian P, Quadri N et al (2015) Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell 59:298–308. doi:10.1016/j.molcel.2015.06.011
11. Jiang L, Kon N, Li T et al (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520:57–62. doi:10.1038/nature14344
12. Dolma S, Lessnick SL, Hahn WC, Stockwell BR (2003) Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3:285–296
13. Yagoda N, von Rechenberg M, Zaganjor E et al (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447:864–868. doi:10.1038/nature05859
14. Torrance CJ, Agrawal V, Vogelstein B, Kinzler KW (2001) Use of isogenic human cancer cells for high-throughput screening and drug discovery. Nat Biotechnol 19:940–945. doi:10.1038/nbt1001-940
15. Shaw AT, Winslow MM, Magendantz M et al (2011) Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proc Natl Acad Sci USA 108:8773–8778. doi:10.1073/pnas.1105941108
16. Weiwer M, Bittker J, Lewis TA et al (2012) Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg Med Chem Lett 22:1822–1826. doi:10.1016/j.bmcl.2011.09.047
17. Yang WS, Stockwell BR (2008) Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol 15:234–245. doi:10.1016/j.chembiol.2008.02.010
18. Wolpaw AJ, Shimada K, Skouta R et al (2011) Modulatory profiling identifies mechanisms of small molecule-induced cell death. Proc Natl Acad Sci USA 108:E771–E780. doi:10.1073/pnas.1106149108
19. Eagle H (1955) Nutrition needs of mammalian cells in tissue culture. Science 122:501–514
20. Eagle H (1959) Amino acid metabolism in mammalian cell cultures. Science 130:432–437
21. Eagle H, Piez KA, Oyama VI (1961) The biosynthesis of cystine in human cell cultures. J Biol Chem 236:1425–1428
22. Bannai S, Tsukeda H, Okumura H (1977) Effect of antioxidants on cultured human diploid fibroblasts exposed to cystine-free medium. Biochem Biophys Res Commun 74:1582–1588
23. Yonezawa M, Back SA, Gan X et al (1996) Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor. J Neurochem 67:566–573
24. De Brabander M, Van Belle H, Aerts F et al (1979) Protective effect of levamisole and its sulfhydryl metabolite OMPI against cell death induced by glutathione depletion. Int J Immunopharmacol 1:93–100
25. Murphy TH, Miyamoto M, Sastre A et al (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547–1558
26. Murphy TH, Schnaar RL, Coyle JT (1990) Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J 4:1624–1633
27. Bauer AJ, Gieschler S, Lemberg KM et al (2011) Functional model of metabolite gating by human voltage-dependent anion channel 2. Biochemistry 50:3408–3410. doi:10.1021/bi2003247
28. Dixon SJ, Patel DN, Welsch M et al (2014) Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 3:e02523. doi:10.7554/eLife.02523
29. Sato H, Tamba M, Ishii T, Bannai S (1999) Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274:11455–11458
30. Gout PW, Buckley AR, Simms CR, Bruchovsky N (2001) Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia 15:1633–1640
31. Ishii T, Bannai S, Sugita Y (1981) Mechanism of growth stimulation of L1210 cells by 2-mercaptoethanol in vitro. Role of the mixed disulfide of 2-mercaptoethanol and cysteine. J Biol Chem 256:12387–12392
32. Larraufie M-H, Yang WS, Jiang E et al (2015) Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility. Bioorg Med Chem Lett. doi:10.1016/j.bmcl.2015.07.018
33. Lachaier E, Louandre C, Godin C et al (2014) Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. Anticancer Res 34:6417–6422
34. Louandre C, Ezzoukhry Z, Godin C et al (2013) Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer 133:1732–1742. doi:10.1002/ijc.28159
35. Panka DJ, Wang W, Atkins MB, Mier JW (2006) The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cells. Cancer Res 66:1611–1619. doi:10.1158/0008-5472.CAN-05-0808
36. Coriat R, Nicco C, Chéreau C et al (2012) Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo. Mol Cancer Ther 11:2284–2293. doi:10.1158/1535-7163.MCT-12-0093
37. Liu L, Cao Y, Chen C et al (2006) Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 66:11851–11858. doi:10.1158/0008-5472.CAN-06-1377
38. Ursini F, Maiorino M, Gregolin C (1985) The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. Biochim Biophys Acta 839:62–70
39. Seiler A, Schneider M, Förster H et al (2008) Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 8:237–248. doi:10.1016/j.cmet.2008.07.005
40. Woo JH, Shimoni Y, Yang WS et al (2015) Elucidating Compound Mechanism of Action by Network Perturbation Analysis. Cell 162:441–451. doi:10.1016/j.cell.2015.05.056
41. Griffith OW, Meister A (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 254:7558–7560
42. Mandal PK, Seiler A, Perisic T et al (2010) System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency. J Biol Chem 285:22244–22253. doi:10.1074/jbc.M110.121327
43. Banjac A, Perisic T, Sato H et al (2008) The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death. Oncogene 27:1618–1628. doi:10.1038/sj.onc.1210796
44. Harris IS, Treloar AE, Inoue S et al (2015) Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression. Cancer Cell 27:211–222. doi:10.1016/j.ccell.2014.11.019
45. May JM, Morrow JD, Burk RF (2002) Thioredoxin reductase reduces lipid hydroperoxides and spares alpha-tocopherol. Biochem Biophys Res Commun 292:45–49
46. Franco R, Cidlowski JA (2009) Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ 16:1303–1314. doi:10.1038/cdd.2009.107
47. Savaskan NE, Borchert A, Bräuer AU, Kuhn H (2007) Role for glutathione peroxidase-4 in brain development and neuronal apoptosis: specific induction of enzyme expression in reactive astrocytes following brain injury. Free Radic Biol Med 43:191–201. doi:10.1016/j.freeradbiomed.2007.03.033
48. Schoeneberger H, Belz K, Schenk B, Fulda S (2015) Impairment of antioxidant defense via glutathione depletion sensitizes acute lymphoblastic leukemia cells for Smac mimetic-induced cell death. Oncogene 34:4032–4043. doi:10.1038/onc.2014.338
49. Macho A, Hirsch T, Marzo I et al (1997) Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J Immunol 158:4612–4619
50. Cheng Z, Li Y (2007) What is responsible for the initiating chemistry of iron-mediated lipid peroxidation: an update. Chem Rev 107:748–766. doi:10.1021/cr040077w
51. Dixon SJ, Winter GE, Musavi LS et al (2015) Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death. ACS Chem Biol 10:1604–1609. doi:10.1021/acschembio.5b00245
52. Soupene E, Kuypers FA (2008) Mammalian long-chain acyl-CoA synthetases. Exp Biol Med (Maywood) 233:507–521. doi:10.3181/0710-MR-287
53. Shindou H, Shimizu T (2009) Acyl-CoA:lysophospholipid acyltransferases. J Biol Chem 284:1–5. doi:10.1074/jbc.R800046200
54. Burczynski ME, Sridhar GR, Palackal NT, Penning TM (2001) The reactive oxygen species–and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha, beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene. J Biol Chem 276:2890–2897. doi:10.1074/jbc.M006655200
55. Schneider C, Porter NA, Brash AR (2008) Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J Biol Chem 283:15539–15543. doi:10.1074/jbc.R800001200
56. Dixon SJ, Stockwell BR (2014) The role of iron and reactive oxygen species in cell death. Nat Chem Biol 10:9–17. doi:10.1038/nchembio.1416
57. Petrat F, de Groot H, Rauen U (2001) Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem J 356:61–69
58. Kuhn H, Banthiya S, van Leyen K (2015) Mammalian lipoxygenases and their biological relevance. Biochim Biophys Acta 1851:308–330. doi:10.1016/j.bbalip.2014.10.002
59. Barradas MA, Jeremy JY, Kontoghiorghes GJ et al (1989) Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity. FEBS Lett 245:105–109
60. Abeysinghe RD, Roberts PJ, Cooper CE et al (1996) The environment of the lipoxygenase iron binding site explored with novel hydroxypyridinone iron chelators. J Biol Chem 271:7965–7972
61. Wang H, Li J, Follett PL et al (2004) 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur J Neurosci 20:2049–2058. doi:10.1111/j.1460-9568.2004.03650.x
62. Li Y, Maher P, Schubert D (1997) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19:453–463
63. Siddiq A, Aminova LR, Troy CM et al (2009) Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways. J Neurosci 29:8828–8838. doi:10.1523/JNEUROSCI.1779-09.2009
64. Kurz T, Gustafsson B, Brunk UT (2006) Intralysosomal iron chelation protects against oxidative stress-induced cellular damage. FEBS J 273:3106–3117. doi:10.1111/j.1742-4658.2006.05321.x
65. Eling N, Reuter L, Hazin J et al (2015) Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2:517–532
66. Schott C, Graab U, Cuvelier N et al (2015) Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell Death. Front Oncol 5:131. doi:10.3389/fonc.2015.00131
67. Hayano M, Yang WS, Corn CK et al (2015) Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ. doi:10.1038/cdd.2015.93
68. Li T, Kon N, Jiang L et al (2012) Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149:1269–1283. doi:10.1016/j.cell.2012.04.026
69. Brady CA, Jiang D, Mello SS et al (2011) Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell 145:571–583. doi:10.1016/j.cell.2011.03.035
70. Bieging KT, Mello SS, Attardi LD (2014) Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14:359–370. doi:10.1038/nrc3711
71. Allen MA, Andrysik Z, Dengler VL et al (2014) Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. Elife 3:e02200. doi:10.7554/eLife.02200
72. Kenzelmann Broz D, Spano Mello S, Bieging KT et al (2013) Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev 27:1016–1031. doi:10.1101/gad.212282.112
73. Tobaben S, Grohm J, Seiler A et al (2011) Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons. Cell Death Differ 18:282–292. doi:10.1038/cdd.2010.92
74. Albrecht P, Lewerenz J, Dittmer S et al (2010) Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target. CNS Neurol Disord: Drug Targets 9:373–382
75. Tan S, Schubert D, Maher P (2001) Oxytosis: a novel form of programmed cell death. Curr Top Med Chem 1:497–506
76. Tan S, Wood M, Maher P (1998) Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J Neurochem 71:95–105
77. Liu Y, Wang W, Li Y et al (2015) The 5-Lipoxygenase Inhibitor Zileuton Confers Neuroprotection against Glutamate Oxidative Damage by Inhibiting Ferroptosis. Biol Pharm Bull 38:1234–1239. doi:10.1248/bpb.b15-00048
78. Henke N, Albrecht P, Bouchachia I et al (2013) The plasma membrane channel ORAI1 mediates detrimental calcium influx caused by endogenous oxidative stress. Cell Death Dis 4:e470. doi:10.1038/cddis.2012.216
79. Green DR, Victor B (2012) The pantheon of the fallen: why are there so many forms of cell death? Trends Cell Biol 22:555–556. doi:10.1016/j.tcb.2012.08.008
80. Troyano A, Fernández C, Sancho P et al (2001) Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation. J Biol Chem 276:47107–47115. doi:10.1074/jbc.M104516200
81. Fernandes RS, Cotter TG (1994) Apoptosis or necrosis: intracellular levels of glutathione influence mode of cell death. Biochem Pharmacol 48:675–681
82. Dai L, Noverr MC, Parsons C et al (2015) xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases. Front Microbiol 6:120. doi:10.3389/fmicb.2015.00120
83. Herzenberg LA, De Rosa SC, Dubs JG et al (1997) Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 94:1967–1972
84. Bhaskar A, Munshi M, Khan SZ et al (2015) Measuring glutathione redox potential of HIV-1-infected macrophages. J Biol Chem 290:1020–1038. doi:10.1074/jbc.M114.588913
85. Green DR, Galluzzi L, Kroemer G (2014) Cell biology. Metabolic control of cell death. Science 345:1250256. doi:10.1126/science.1250256
86. Gokce G, Ozsarlak-Sozer G, Oktay G et al (2009) Glutathione depletion by buthionine sulfoximine induces oxidative damage to DNA in organs of rabbits in vivo. Biochemistry 48:4980–4987. doi:10.1021/bi900030z
87. Sun X, Ou Z, Xie M et al (2015) HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene. doi:10.1038/onc.2015.32
88. Lőrincz T, Jemnitz K, Kardon T et al (2015) Ferroptosis is involved in acetaminophen induced cell death. Pathol Oncol Res 1–7. doi:10.1007/s12253-015-9946-3
89. Matsushita M, Freigang S, Schneider C et al (2015) T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med 212:555–568. doi:10.1084/jem.20140857